Form 8-K - Current report:
SEC Accession No. 0001437749-23-012423
Filing Date
2023-05-04
Accepted
2023-05-04 08:00:23
Documents
15
Period of Report
2023-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K amtx20230503_8k.htm   iXBRL 8-K 24247
2 EXHIBIT 99.1 EARNINGS RELEASE ex_513372.htm EX-99.1 76365
7 ex_513372img001.jpg GRAPHIC 3706
  Complete submission text file 0001437749-23-012423.txt   249278

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amtx-20230504.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amtx-20230504_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amtx-20230504_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amtx-20230504_pre.xml EX-101.PRE 11688
9 EXTRACTED XBRL INSTANCE DOCUMENT amtx20230503_8k_htm.xml XML 2560
Mailing Address 20400 STEVENS CREEK BLVD SUITE 700 CUPERTINO CA 95014
Business Address 20400 STEVENS CREEK BLVD SUITE 700 CUPERTINO CA 95014 408-517-3304
AEMETIS, INC (Filer) CIK: 0000738214 (see all company filings)

EIN.: 261407544 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36475 | Film No.: 23886596
SIC: 2860 Industrial Organic Chemicals